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BY-NC-ND license (http://creativecomAbstract The prognostic importance of plateletelymphocyte ratio (PLR) is already known for
various artery diseases. In this study, the relationship between PLR and severity of erectile
dysfunction (ED) is examined in patients with impotence. The data from patients suffering
from erection problems was screened retrospectively. Detailed medical history, age, Interna-
tional Index of Erectile Function-5 (IIEF-5) scores, fasting blood glucose, lipid, whole blood
count, and hormone profile values were examined. Patients with no ED were selected as the
control group. All men answered the IIEF-5 questions and were then classified according to
their scores. Patients were determined to have severe ED (scores 5e7), moderate ED (scores
8e16), or mild ED (scores 17e21). An IIEF-5 score greater than 21 was accepted for the control
group. The PLR values from both patient and control groups were evaluated. Demographic data
were similar in both groups. Mean PLR value was 104 in control and 118 in the patient group
(p < 0.001). PLR value increased depending on the severity of ED. Mean PLR values were
108 in mild, 116 in moderate, and 130 in severe ED groups. Compared with the control group,
this value was statistically significant for patients with moderate and severe ED (pZ 0.04 and
p < 0.001). PLR showed weak negative but significant correlation with IIEF-5 scores (rZ 0.27
and p < 0.001). The PLR value was found to be higher in patients with ED. PLR value may be
related to ED and its severity in patients with impotence.
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Table 1 General characteristics and whole blood counts
of the study population.
Control
group
N Z 175
Erectile
dysfunction
group
N Z 262
p*
Age (y) 53.8  8.4 54  11.7 0.4
Body mass index
(kg/m2)
27.3  2.6 27.1  2.9 0.4
Prolactin (ng/mL) 5.8  2.7 6  3.3 0.3
Testosterone
(ng/mL)
5.6  2.1 5.4  2.5 0.4
Fasting blood
glucose (mg/dL)
86.3  8.8 91.1  9.2 0.23
Total cholesterol
(mg/dL)
196.6  15.3 192.8  13.3 0.2
LDL cholesterol
(mg/dL)
107 (58e135) 115 (55e139) 0.3
HDL cholesterol
(mg/dL)
45 (33e73) 38 (29e67) 0.06
Smoking, N (%) 40 (23) 65 (25) 0.32
WBC (103/mm3) 7.7  1.6 8.1  2.1 0.51
Platelet (103/mm3) 225.4  42 238.8  64 0.09
Neutrophil
(103/mm3)
4.6  1.3 4,7  1.7 0.86
Lymphocyte
(103/mm3)
2.3  0.8 2.1  0.6 0.08
Hematocrit (%) 43.8  3.5 43.4  4.1 0.7
NLR 2.16  0.9 2.44  1.3 0.08
PLR 104.7  6.9 118.3  7.7 <0.001
Mean platelet
volume (fL)
11.7  2.5 14.05  3.3 <0.001
* p < 0.05 was considered statistically significant.
HDLZ high density lipoprotein; LDLZ low density lipoprotein;
NLRZ neutrophil lymphocyte ratio; PLRZ platelet lymphocyte
ratio; WBC Z white blood cell.
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Erectile dysfunction (ED) is described as an inability to
stiffen and sustain an erection long enough for sexual in-
tercourse [1]. It is a disorder that usually affects men be-
tween the ages of 40 years and 70 years and reduces their
quality of life. It may be caused not only by endocrine,
neurological, and psychological causes, but also may be a
side effect of some medicines. Erection occurs due to a
neurovascular process under hormonal control. Today, the
International Index of Erectile Function-5 scoring system
(IIEF-5) questionnaire is used in order to evaluate erectile
function [2].
Risk factors for cardiovascular disease such as hyper-
cholesterolemia, obesity, consumption of tobacco prod-
ucts, lack of exercise, and metabolic syndrome, are also
risk factors for ED. Therefore, coronary artery diseases can
be associated with vasculogenic ED [3].
Publications in recent years have emphasized the prog-
nostic importance of plateletelymphocyte ratio (PLR) for
coronary artery diseases, various oncological diseases, and
especially in acute coronary syndromes [4e8]. Increased
PLR value in these diseases is an indication of poor
prognosis.
The importance of PLR is unknown for ED patients,
though they may share many common characteristics with
acute coronary syndromes. There is no specific blood
parameter showing ED. In this study, the relationship be-
tween PLR and ED (and its severity) was examined in pa-
tients with impotence.
Methods
The patients were screened after permission was received
from C¸anakkale Onsekiz Mart University Clinical Research
Ethics Committee (2014-25; Canakkale, Turkey).
The study included patients suffering from erection
problems who attended the urology clinics of two university
hospitals between 2009 and 2013. Detailed medical history,
age, IIEF-5 scores, fasting blood glucose, lipid, whole blood
count, and hormone profile values were included in the
study. Men with no ED comprised the control group. These
patients applied to the urology clinics for urological rea-
sons, such as renal cyst, hydrocele, inguinal hernia, etc.
The inclusion criteria for the control group were whole
blood count, no sexual problems, and an IIEF-5 score over
21. Lipid and hormone profiles were obtained from the
hospital information system. Informed consent was ob-
tained from the control group and patients who attended
the hospital because of incomplete medical history. Pa-
tients reached by phone or those whose data were obtained
from the hospital information system did not provide
informed consent.
Patients were included in this study after examining
their detailed sexual history and eliminating possible un-
derlying reasons for impotence. Patients were excluded if
they had any inflammatory, cardiovascular, and/or hema-
tologic (such as leukocytosis and trombocytopenia) dis-
eases, psychogenic reasons, hormonal disorders
(hyperprolactinemia, hypogonadism), or neurological dis-
orders (multiple sclerosis and seizure), failure to obtaintheir hemograms, findings of infection, or the use of med-
icines affecting blood count and erectile function (anti-
aggregants, beta blockers, and antidepressants). Further-
more diabetic or hypertensive patients were excluded. In-
dividuals who did not have a sexual relationship for over a
year or without a sexual partner were also excluded from
the study. All men were asked to complete the IIEF-5 form
(used for evaluation of erectile dysfunction) and were
divided into four groups according to their scores. Patients
with an IIEF-5 score between 22 and 25 were defined as the
control group. Patients with a score between 17 and 21
were defined as mild ED, between 8 and 16 as moderate ED,
and between 5 and 7 as severe ED. Complete blood counts
from all patients, fasting blood glucose, lipid, and hormone
profile levels were recorded from their files.
The KolmogoroveSmirnov test was used to determine
whether the sampling was normally distributed. Continuous
variables are summarized as mean  standard deviation.
Two independent and one-way analysis of variance tests
were used as parametric tests. The KruskaleWallis variance
and the ManneWhitney U test were used as nonparametric
tests. Discrete variables are presented as frequency and
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lation and linear regression analysis were used to deter-
mine the relationship between variables. The associations
between IIEF-5 scores (dependent variable) and indepen-
dent variables were analyzed using linear regression.
Multivariate models were adjusted for age, cholesterol,
triglyceride, low-density lipoprotein (LDL), testosterone,
follicle-stimulating hormone (FSH), PLR, and prolactin. All
variables were continuous.
All tests were two-tailed and p < 0.05 was considered
statistically significant. IBM SPSS Statistics version 19 (SPSS
Inc., Chicago, IL, USA) was used for statistical analysis.Results
Six hundred and fifty patients were screened but 213 were
excluded from the study. The remaining 437 men were
included in the study. A total of 262 ED patients and 175
non-ED individuals (control group) were enrolled. Mean age
was 53.8  8.4 years in the control group and
54  14.8 years in the patient group (p Z 0 .42). De-
mographic and hemogram parameters from both groups
were compared and found to be similar (Table 1). When ED
and non-ED groups are compared using the ManneWhitney
U test according to their blood parameters and age, the p
values were not statistically significant. The p values for
age, cholesterol, triglyceride, LDL, testosterone, FSH, and
prolactin were 0.4, 0.5, 0.2, 0.052, 0.1, 0.2 and 0.09,
respectively. Platelet and lymphocyte counts were 224.4
and 2 in the control group and 237.8 and 2.2 in the ED
group, respectively. When PLR values of ED and non-ED
groups are evaluated, it was determined that PLR signifi-
cantly increased in patients with ED. Mean PLR value was
104.75  5.7 in the control group and 118.14  6.6 in the
patient group (p < 0.001). Sixty-four patients were in the
mild ED group and mean PLR value was 108. The mean PLR
value of 115 moderate ED patients was 116 and for 83 se-
vere ED patients was 130. PLR value was statistically sig-
nificant between all groups (p < 0.001). In terms of PLRFigure 1. The plateletelymphocyte ratio value is increased in
control group (p Z 0.04 and p < 0.001). ED Z erectile dysfunctiovalue, the groups based on severity of ED were compared
with the control group. All the comparisons with the
ManneWhitney U test were statistically significant, except
for mild ED. The PLR value is statistically increased in
moderate and severe ED compared with the control group
(pZ 0.04 and p < 0.001; Figure 1). An increase in PLR value
was also detected in patients with mild ED but this was not
considered to be statistically significant.
When all the variables are examined, a negative corre-
lation was determined between PLR and IIEF-5 scores
(partial correlation coefficient Z 0.27 and p < 0.001).
The multivariate linear regression model showed that total
cholesterol, triglyceride, LDL, testosterone, FSH, prolactin
levels, and age were not related to IIEF-5 scores (Table 2).Discussion
In this study, we found that PLR was higher in patients with
ED than in the control group. Additionally, we showed that
PLR was correlated with severity of ED. As a result the
present study shows that PLR may predict the likely
outcome of diagnosis with ED.
The incidence of ED increases with age [1]. ED affects
the quality of life of the patient and his partner negatively.
Many mechanisms have roles in the pathophysiology of ED.
The leading factors include neurogenic, hormonal,
vascular, iatrogenic, and psychogenic factors [9]. Currently,
atherosclerosis (AS) is accepted as the main organic reason
for ED [9e11]. Moreover, the risk factors (diabetes mellitus,
hypertension, hyperlipidemia, smoking, obesity, and
sedentary life style) for vasculogenic ED and AS are similar
[9].
PLR calculated from whole blood count is an easily
obtainable test. The whole blood count is frequently per-
formed on admission to hospital for the majority of patients.
Platelet counts affect PLR by causing a change in blood
viscosity and this may be one of the reasons for this finding.
Increased platelet count is common in cases of inflammation
and may be found in patients with active AS and show amoderate and severe erectile dysfunction compared with the
n.
Table 2 Linear multivariable regression analysis of In-
ternational Index of Erectile Function-5 scores.
Variable B Beta 95% CI p
Constant
(IIEF-5)a
20.2 14.9e25.5 <0.001
PLR 0.045 0.273* 0.06e0.029 <0.001*
Age 0.020 0.031 0.041e0.081 0.518
Cholesterol 0.006 0.031 0.035e0.022 0.658
Triglyceride 0.002 0.030 0.009e0.005 0.571
LDL 0.029 0.115 0.004e0.062 0.085
Testosterone 0.009 0.021 0.047e0.029 0.652
FSH 0.044 0.039 0.149e0.061 0.413
* Associations that are statistically significant.
CI Z confidence interval; FSH Z follicle stimulating hormone;
IIEF-5 Z International Index of Erectile Function-5; LDL Z low
density lipoprotein.
a The effect of each continuous variable on IIEF-5 score was
determined using a multivariable linear regression model. In
this study, PLR was the only variable affecting IIEF-5 score
(r Z 0.27, p < 0.001).
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important role in the progression of AS. According to recent
studies, platelets interact with endothelial cells and leu-
kocytes [13] and release inflammatory substances causing
adhesion and transmigration of monocytes [14]. Inflamma-
tory processes are supported bymonocytes in the vessel wall
promoting the development of atherosclerotic lesions [15].
Vascular disease is the most common reason for ED. In a
recent study, arterial insufficiency was demonstrated using
color Doppler sonography performed on patients with ED to
evaluate cavernosal arteries after an intracavernosal in-
jection of a vasodilatory agent [16]. ED is related with
subclinical AS, deterioration of arterial function, and sys-
temic endothelial and inflammatory activation [17].
Atherogenesis including coagulation increases leukocyte
adhesion and stimulation of smooth muscle cell growth
[18]. Some authors concluded that penile cavernosal artery
intima-media thickness was increased in patients with
erectile dysfunction [18,19]. In another study in patients
with ED caused by arterial problems, a peripheral arterial
atherosclerotic process in the femoral artery was found to
be higher than in the control group.
The relationship between mean platelet volume (MPV)
and ED was described in two studies. La Vignera et al [20]
showed that in arterial ED patients with no cardiovascular
risk factors, there was a positive correlation between MPV
and vitronectin receptor and these parameters might be
cardiovascular risk factors in arterial ED patients. In the
second paper by Ciftci et al [21], MPV was shown to be
significantly higher in vasculogenic ED patients than in
nonvasculogenic ED patients. Consequently, these studies
show that platelet volume and functions may play a role in
the pathogenesis of ED. Both MPV and PLR values were
found to be higher in the ED group in our study as well. We
used PLR as a new marker and risk factor for ED. Increased
PLR value in cardiovascular diseases may also be used as a
predictor for vasculogenic ED. Moreover higher PLR values
correlate with severity of ED.The vast majority of patients did not have penile color
Doppler ultrasonography scans in the ED group and this
problem is a limitation of our study. The comparison
between penile Doppler ultrasonography results and PLR
value was not performed. This limitation arises due to
ethical reasons, missing records, and difficulties in
reaching data. Future studies will examine the PLR values
of patients with arteriogenic and venogenic ED. The
second limitation was excluding patients with diabetes
and hypertension. These two diseases are the main
risk factors for vasculogenic ED. Because of this our
study population was highly selective; therefore, the
changes of PLR value cannot be valid for all the patients
with ED.
We demonstrated that PLR is higher in patients with ED
than in the control group and it is related to severity of ED.
PLR and other inflammatory markers and clinical findings
might be helpful in identifying patients with ED and
developing treatment strategies.References
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